110 related articles for article (PubMed ID: 17241428)
21. Codelivery of Doxorubicin and Verapamil for Treating Multidrug Resistant Cancer Cells.
Williams JB; Buchanan CM; Pitt WG
Pharm Nanotechnol; 2018; 6(2):116-123. PubMed ID: 30207210
[TBL] [Abstract][Full Text] [Related]
22. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Vilpo J; Koski T; Vilpo L
Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
[TBL] [Abstract][Full Text] [Related]
23. Pingyangmycin loaded bovine serum albumin microspheres for chemoembolization therapy--in vitro and in vivo studies.
Wang C; Liu J; Pan W; Wang X; Gao Q; Hou S
Int J Pharm; 2008 Mar; 351(1-2):219-26. PubMed ID: 18054185
[TBL] [Abstract][Full Text] [Related]
24. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
Wang WG; Wang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
[TBL] [Abstract][Full Text] [Related]
25. Neochlorogenic acid enhances the antitumor effects of pingyangmycin via regulating TOP2A.
Che J; Zhao T; Liu W; Chen S; Yang G; Li X; Liu D
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355372
[TBL] [Abstract][Full Text] [Related]
26. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients.
Bai N; Chen YZ; Fu YJ; Wu P; Zhang WN
J Clin Pharm Ther; 2014 Oct; 39(5):521-6. PubMed ID: 24924412
[TBL] [Abstract][Full Text] [Related]
27. [Cytotoxicity of chymopapain combined with pingyangmycin on mouse hepatoma cell line hepa-6].
Xiaoling C; Jie W; Yong G; Taicheng Y; Jiang X
Zhong Yao Cai; 2004 Apr; 27(4):267-9. PubMed ID: 15307684
[TBL] [Abstract][Full Text] [Related]
28. Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations.
Chen F; Song S; Wang H; Zhang W; Lin C; Ma S; Ye T; Zhang L; Yang X; Qin X; Pan W
Int J Pharm; 2014 Dec; 476(1-2):232-40. PubMed ID: 25283699
[TBL] [Abstract][Full Text] [Related]
29. Phosphoinositide 3-kinase/Akt pathway is involved in pingyangmycin‑induced growth inhibition, apoptosis and reduction of invasive potential in EOMA mouse hemangioendothelioma cells.
Peng LX; Zhao P; Zhao HS; Pan E; Yang BB; Li Q
Mol Med Rep; 2015 Dec; 12(6):8275-81. PubMed ID: 26498320
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of different modes of cell death upon herpes simplex virus 1 infection in different types of oral cells.
Huang CR; Lin SS; Chou MY; Ho CC; Wang L; Lee YL; Chen CS; Yang CC
Acta Virol; 2005; 49(1):7-15. PubMed ID: 15929393
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of lidocaine with pingyangmycin for treatment of venous malformation using a mouse spleen model.
Bai N; Chen YZ; Mao KP; Fu Y; Lin Q; Xue Y
Int J Clin Exp Pathol; 2014; 7(5):2324-36. PubMed ID: 24966943
[TBL] [Abstract][Full Text] [Related]
32. [Anticancer spectrum of pingyangmycin in vitro].
Li XT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):182-6. PubMed ID: 1706647
[TBL] [Abstract][Full Text] [Related]
33. [Embolization and degradation of arteries in vivo by pingyangmycin albumin microspheres].
Wang LL; Gao QH; Zheng GJ; Wang XY; Zhou L; Wang CM; Wen YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):279-83. PubMed ID: 19462907
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of Cytotoxicity of Three Apoptosis-inducing Agents Against Human Oral Squamous Cell Carcinoma Cell Line by Benzoxazinotropone.
Tomikoshi Y; Nomura M; Okudaira N; Sakagami H; Wakabayashi H
In Vivo; 2016 09-10; 30(5):645-50. PubMed ID: 27566085
[TBL] [Abstract][Full Text] [Related]
36. [Effects of pingyangmycin on the growth and differentiation of the transplantable squamous cell carcinoma of forestomach (GS-742) in mice].
Wang FR
Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):326-8. PubMed ID: 2482804
[TBL] [Abstract][Full Text] [Related]
37. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
[TBL] [Abstract][Full Text] [Related]
38. Chitosan-based liposomal thermogels for the controlled delivery of pingyangmycin: design, optimization and in vitro and in vivo studies.
Zhang L; Chen F; Zheng J; Wang H; Qin X; Pan W
Drug Deliv; 2018 Nov; 25(1):690-702. PubMed ID: 29484910
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo induction of apoptosis by sphingosine and N, N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells.
Shirahama T; Sweeney EA; Sakakura C; Singhal AK; Nishiyama K; Akiyama S; Hakomori S; Igarashi Y
Clin Cancer Res; 1997 Feb; 3(2):257-64. PubMed ID: 9815681
[TBL] [Abstract][Full Text] [Related]
40. [Effect of bleomycin A5 on the hemangioma-derived endothelial cell line XTPS-1].
Li P; Xiao XE; Guo ZT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jun; 47(6):324-8. PubMed ID: 22932480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
